CBWTF Stock Chart & Stats
$2.25
--
At close: 4:00 PM EDT
$2.25
--
Day’s Range― - ―
52-Week Range$1.06 - $2.39
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.04M
Market Cap
$233.77M
Enterprise Value$301.99
Total Cash (Recent Filing)$38.95M
Total Debt (Recent Filing)$53.67M
Price to Earnings (P/E)9.7
Beta0.45
Next Earnings
Nov 16, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.33
Shares Outstanding103,235,435
10 Day Avg. Volume1,190,854
30 Day Avg. Volume1,035,144
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.09
Price to Sales (P/S)1.27
P/FCF Ratio8.25
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$2.89Price Target Upside28.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.1
Revenue Forecast (FY)$116.67M
Bulls Say, Bears Say
Bulls Say
Improved ProfitabilityThe shift to positive earnings and solid operating profitability indicates a meaningful business turnaround. Sustained profitability can strengthen internal funding, improve resilience against industry pricing pressure, and support continued investment in branded cannabis products.
Strong Cash GenerationPositive operating and free cash flow provide financial flexibility without relying as heavily on external funding. Strong conversion of earnings into cash can support working capital, product development, and debt management across the regulated cannabis cycle.
Reduced LeverageThe substantial reduction in leverage lowers balance-sheet risk and interest burden relative to the company’s stressed earlier periods. Greater equity support and improved returns increase financial flexibility to manage competition, compliance costs, and operating volatility.
Bears Say
Slowing Revenue GrowthSlower growth suggests that the initial recovery is losing momentum and that further expansion may depend on winning shelf space, increasing product adoption, or improving mix. Persistent moderation could limit operating leverage and constrain future earnings growth.
Margin CompressionA substantial margin decline indicates pressure from costs, pricing, or product mix despite continued profitability. If structural, compression could reduce the benefit of revenue growth and weaken cash generation, making consistent execution and premium product positioning important.
Cyclical Cash-Flow HistoryCurrent cash generation is strong, but the history of negative cash flow shows that performance has not been consistently self-funded across the cycle. Slightly negative recent FCF growth adds execution risk if profitability or working-capital conditions deteriorate.
Auxly Cannabis Group News
CBWTF FAQ
What was Auxly Cannabis Group’s price range in the past 12 months?
Auxly Cannabis Group lowest stock price was $1.06 and its highest was $2.39 in the past 12 months.
What is Auxly Cannabis Group’s market cap?
Auxly Cannabis Group’s market cap is $233.77M.
When is Auxly Cannabis Group’s upcoming earnings report date?
Auxly Cannabis Group’s upcoming earnings report date is Nov 16, 2026 which is in 79 days.
How were Auxly Cannabis Group’s earnings last quarter?
Auxly Cannabis Group released its earnings results on Aug 13, 2026. The company reported $0.05 earnings per share for the quarter, the consensus estimate of $0.05 by $0.
Is Auxly Cannabis Group overvalued?
According to Wall Street analysts Auxly Cannabis Group’s price is currently Undervalued.
Does Auxly Cannabis Group pay dividends?
Auxly Cannabis Group does not currently pay dividends.
What is Auxly Cannabis Group’s EPS estimate?
Auxly Cannabis Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Auxly Cannabis Group have?
Auxly Cannabis Group has 103,235,435 shares outstanding.
What happened to Auxly Cannabis Group’s price movement after its last earnings report?
Auxly Cannabis Group reported an EPS of $0.05 in its last earnings report, expectations of $0.05. Following the earnings report the stock price went down -6.913%.
Which hedge fund is a major shareholder of Auxly Cannabis Group?
Currently, no hedge funds are holding shares in CBWTF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Auxly Cannabis Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.89 (28.40% Upside)
$2.89 (28.40% Upside)
Insider Transactions
Bought Shares
Worth $1.2M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
182.85%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.77%
Trailing 12-Months
Company Description
Auxly Cannabis Group
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis formats under its distinct brands—KOLAB PROJECT, Dosecann, BACK FORTY, and Foray—including vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. Originally incorporated in 1987, the company was known as Cannabis Wheaton Income Corp. before officially changing its name to Auxly Cannabis Group Inc. in June 2018. It is headquartered in Toronto, Canada.
CBWTF Earnings Call
Q2 2026
0:00 / 0:00
CBWTF Stock 12 Month Forecast
Average Price Target
$2.89
▲(28.40% Upside)